American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

被引：484

作者：

Grossman, Jennifer M. ^{[1
]}

Gordon, Rebecca ^{[1
,2
]}

Ranganath, Veena K. ^{[1
]}

Deal, Chad ^{[3
]}

Caplan, Liron ^{[4
]}

Chen, Weiling ^{[1
]}

Curtis, Jeffrey R. ^{[5
]}

Furst, Daniel E. ^{[1
]}

McMahon, Maureen ^{[1
]}

Patkar, Nivedita M. ^{[5
]}

Volkmann, Elizabeth ^{[1
]}

Saag, Kenneth G. ^{[5
]}

机构：

[1] Univ Calif Los Angeles, Los Angeles, CA 90095 USA

[2] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA

[3] Cleveland Clin, Cleveland, OH 44106 USA

[4] Univ Colorado, Denver, CO 80202 USA

[5] Univ Alabama Birmingham, Birmingham, AL USA

来源：

ARTHRITIS CARE & RESEARCH | 2010年 / 62卷 / 11期

关键词：

CORTICOSTEROID-INDUCED OSTEOPOROSIS; BONE-MINERAL DENSITY; INTERMITTENT CYCLICAL ETIDRONATE; VERTEBRAL FRACTURE ASSESSMENT; RANDOMIZED CONTROLLED-TRIAL; CONNECTIVE-TISSUE DISEASE; HIGH-DOSE GLUCOCORTICOIDS; CHRONIC STEROID-THERAPY; DOUBLE-BLIND; VITAMIN-D;

D O I：

10.1002/acr.20295

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.

引用

页码：1515 / 1526

页数：12

共 50 条

[21] Glucocorticoid-induced osteoporosis: Prevention and treatment
Ziegler, R
Kasperk, C
[J]. STEROIDS, 1998, 63 (5-6) : 344 - 348
[22] PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS
LIBANATI, C
[J]. CHEST, 1993, 104 (06) : 1936 - 1936
[23] Prevention and treatment of glucocorticoid-induced osteoporosis
Lane, NF
Lukert, B
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1999, 5 (05) : S16 - S22
[24] Prevention and treatment of glucocorticoid-induced osteoporosis
Eggelmeijer, F
[J]. PHARMACY WORLD & SCIENCE, 1998, 20 (05): : 193 - 197
[25] Glucocorticoid-induced osteoporosis: Prevention and treatment
Werth, VP
[J]. REVUE DU RHUMATISME, 1997, 64 (06): : S84 - S88
[26] Prevention and treatment of glucocorticoid-induced osteoporosis
Curtis J.R.
Saag K.G.
[J]. Current Osteoporosis Reports, 2007, 5 (1) : 14 - 21
[27] Glucocorticoid-induced osteoporosis: Prevention and treatment
Coutlakis, P
Buckley, LM
[J]. BULLETIN ON THE RHEUMATIC DISEASES, 2000, 49 (04) : 1 - 4
[28] Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis
Compston, JE
Audran, M
Avouac, B
Bouvenot, G
Devogelaer, JP
Eastell, R
Fabris, F
Gennari, C
Jones, EA
Kaufman, JM
Lemmel, EM
Mazzuoli, G
Reid, DM
Ringe, JD
Vanhaelst, L
Ziegler, R
Reginster, JY
[J]. CALCIFIED TISSUE INTERNATIONAL, 1996, 59 (05) : 323 - 327
[29] Assessment and Treatment of Glucocorticoid-Induced Osteoporosis in a Rheumatology Clinic
Stefl, Amanda
Singla, Shikha
Michaud, Jessica
Thomas, Kama
Rein, Lisa
Csuka, Mary Ellen
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[30] German Society of Rheumatology Recommendations for the Management of Glucocorticoid-induced Osteoporosis (2021)
Leipe, Jan
Holle, Julia U.
Weseloh, Christiane
Pfeil, Alexander
Krueger, Klaus
[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (03): : 263 - 263

← 1 2 3 4 5 →